Free tool
Medical devices stocks
We cover 47 companies grouped under the Medical devices theme. The median market value in the group is $33.48M. Across the group, the median move over the past trading day is 0.00%. 48% of the 46 with a 200-day average trade above it. Price change over the past year runs from −68.0% to +54.5% across the middle 80 percent of the group, with a median of −5.5%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
47 of 349 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| 0VAG.L | Novanta Inc. | $4.84B | Mid cap | +21.55% |
| 0QLQ.L | Ypsomed Holding AG | $4.65B | Mid cap | +2.80% |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% |
| 0A05.L | Medacta Group SA | $4.10B | Mid cap | −10.46% |
| 0JRJ.L | Knowles Corporation | $3.39B | Mid cap | +63.02% |
| ASKER.ST | Asker Healthcare Group AB (publ) | $2.99B | Mid cap | −24.65% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| GNN.DE | GN Store Nord A/S | $2.44B | Mid cap | −19.86% |
| CREO.L | Creo Medical Group PLC | $85.82M | Micro cap | −1.90% |
| VLT.MI | Valtecne S.p.A. | $84.06M | Micro cap | +64.70% |
| OBI.L | Ondine Biomedical Inc. | $81.20M | Micro cap | −24.19% |
| ALTHE.PA | Theraclion SA | $55.29M | Micro cap | −22.30% |
| ALSMA.PA | S.M.A.I.O S.A. | $54.96M | Micro cap | +14.29% |
| BACTI-B.ST | Bactiguard Holding AB (publ) | $52.93M | Micro cap | −46.25% |
| SVS.MI | Svas Biosana S.p.A. | $50.68M | Micro cap | +0.98% |
| CLBIO.ST | Corline Biomedical AB | $45.27M | Micro cap | +45.56% |
| 0H8I.L | Accuray Incorporated | $41.25M | Micro cap | −82.97% |
| ALMKT.PA | Mauna Kea Technologies SA | $37.11M | Micro cap | +47.33% |
| CAR.L | Carclo plc | $36.62M | Micro cap | −23.21% |
| BRETEC.HE | Bioretec Oy | $33.48M | Micro cap | −98.25% |
| BRAIN.ST | BrainCool AB (publ) | $32.34M | Micro cap | −21.51% |
| ALIMP.PA | Implanet S.A. | $31.22M | Micro cap | −2.68% |
| ALDMS.PA | Diagnostic Medical Systems S.A. | $30.62M | Micro cap | −25.62% |
| ACUVI.ST | Acuvi AB | $30.12M | Micro cap | −64.38% |
| AAQ1.DE | aap Implantate AG | $25.22M | Micro cap | −15.12% |
| RUA.L | RUA Life Sciences plc | $24.04M | Micro cap | +130.93% |
| IHC.L | Inspiration Healthcare Group plc | $22.54M | Micro cap | −19.74% |
| X74.F | I.M.D. International Medical Devices S.p.A. | $20.60M | Micro cap | −22.17% |
| ALEMG.PA | Laboratoires Euromedis Société anonyme | $16.52M | Micro cap | +18.10% |
| 7820.F | Scandinavian Real Heart AB (Publ) | $15.85M | Micro cap | +1.60% |
| GME.DE | Geratherm Medical AG | $15.65M | Micro cap | −16.50% |
| ARCOMA.ST | Arcoma AB | $12.17M | Micro cap | −2.13% |
| ALSGD.PA | SpineGuard SA | $10.62M | Micro cap | +8.08% |
| CMOTEC-B.ST | Scandinavian ChemoTech AB | $10.10M | Micro cap | −19.74% |
| BIBB.ST | BiBBInstruments AB | $9.70M | Micro cap | −84.94% |
| CLS-B.ST | Clinical Laserthermia Systems AB (publ) | $9.27M | Micro cap | −75.86% |
| PRE.MI | Predict S.p.A. | $8.17M | Micro cap | +7.51% |
| AWM.WA | Airway Medix S.A. | $7.14M | Micro cap | −31.11% |
| 0P5I.L | Mauna Kea Technologies SA | $6.70M | Micro cap | +48.85% |
| ALSPW.PA | Spineway SA | $5.40M | Micro cap | +3.24% |
| SUN.L | Surgical Innovations Group plc | $5.39M | Micro cap | −39.29% |
| BIG1.DE | Bio-Gate AG | $1.55M | Micro cap | +200.53% |
| ALSAF.PA | Safe Orthopaedics SA | $148.67K | Micro cap | −73.33% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.